Telmisartan for treatment of Covid-19 patients: An open multicenter randomized clinical trial

BACKGROUND: Angiotensin receptor blockers (ARBs), such as telmisartan, have been postulated to treat Covid-19-induced lung inflammation. METHODS: This is a parallel-group, randomized, two-arm, open-label, adaptive, multicenter superiority trial with 1:1 allocation ratio. Participants included patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Duarte, Mariano, Pelorosso, Facundo, Nicolosi, Liliana N., Victoria Salgado, M., Vetulli, Héctor, Aquieri, Analía, Azzato, Francisco, Castro, Marcela, Coyle, Javier, Davolos, Ignacio, Criado, Ignacio Fernandez, Gregori, Rosana, Mastrodonato, Pedro, Rubio, María C., Sarquis, Sergio, Wahlmann, Fernando, Rothlin, Rodolfo P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225700/
https://www.ncbi.nlm.nih.gov/pubmed/34189447
http://dx.doi.org/10.1016/j.eclinm.2021.100962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225700/
https://www.ncbi.nlm.nih.gov/pubmed/34189447
http://dx.doi.org/10.1016/j.eclinm.2021.100962

Ejemplares similares